515
Views
7
CrossRef citations to date
0
Altmetric
Brief Report

Alpha2C-adrenoceptor Del322-325 polymorphism and risk of psychiatric disorders: significant association with opiate abuse and dependence

, , , , , , & show all
Pages 308-315 | Received 06 Oct 2015, Accepted 11 Jan 2016, Published online: 23 Mar 2016

References

  • Barr CL, Wigg K, Zai G, Roberts W, Malone M, Schachar R, et al. 2001. Attention-deficit hyperactivity disorder and the adrenergic receptors α1C and α2C. Mol Psychiatry. 6:334–337.
  • Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc Series B. 57:289–300.
  • Brent DA, Melhem N. 2008. Familial transmission of suicidal behavior. Psychiatr Clin North Am. 31:157–177.
  • Brodie MS, Shefner SA, Dunwiddie TV. 1990. Ethanol increases the firing rate of dopamine neurons of the rat ventral tegmental area in vitro. Brain Res. 508:65–69.
  • Bücheler MM, Hadamek K, Hein L. 2002. Two alpha(2)-adrenergic receptor subtypes, alpha(2A) and alpha(2C), inhibit transmitter release in the brain of gene-targeted mice. Neuroscience. 109:819–826.
  • Burcescu I, Wigg K, Gomez L, King N, Vetró Á, Kiss E, et al. 2006. Association study of the adrenergic receptors and childhood-onset mood disorders in Hungarian families. Am J Med Genet – Neuropsychiatr Genet. 141 B:227–233.
  • Callado LF, Meana JJ, Grijalba B, Pazos A, Sastre M, García-Sevilla JA. 1998. Selective increase of alpha2A-adrenoceptor agonist binding sites in brains of depressed suicide victims. J Neurochem. 70:1114–1123.
  • Chabot-Doré A-J, Schuster DJ, Stone LS, Wilcox GL. 2015. Analgesic synergy between opioid and α2-adrenoceptors. Br J Pharmacol. 172:388-402.
  • Chen W, Song B, Marvizón JCG. 2008. Inhibition of opioid release in the rat spinal cord by alpha2C adrenergic receptors. Neuropharmacology. 54:944–953.
  • Comings DE, Gade-Andavolu R, Gonzalez N, Wu S, Muhleman D, Chen C, et al. 2001. The additive effect of neurotransmitter genes in pathological gambling. Clin Genet. 60:107–116.
  • De Luca V, Vincent JB, Müller DJ, Hwang R, Shinkai T, Volavka J, et al. 2005. Identification of a naturally occurring 21 bp deletion in alpha 2c noradrenergic receptor gene and cognitive correlates to antipsychotic treatment. Pharmacol Res. 51:381–384.
  • De Vos H, Vauquelin G, De Keyser J, De Backer JP, Van Liefde I. 1992. Regional distribution of alpha 2A- and alpha 2B-adrenoceptor subtypes in postmortem human brain. J Neurochem. 58:1555–1560.
  • Fairbanks CA, Stone LS, Kitto KF, Nguyen HO, Posthumus IJ, Wilcox GL. 2002. alpha(2C)-Adrenergic receptors mediate spinal analgesia and adrenergic-opioid synergy. J Pharmacol Exp Ther. 300:282–290.
  • Feng J, Zheng J, Gelernter J, Kranzler H, Cook E, Goldman D, et al. 2001. An in-frame deletion in the alpha(2C) adrenergic receptor is common in African-Americans. Mol Psychiatry. 6:168–172.
  • Gabilondo AM, Meana JJ, Barturen F, Sastre M, Garcia-Sevilla JA. 1994. μ-Opioid receptor and α2-adrenoceptor agonist binding sites in the postmortem brain of heroin addicts. Psychopharmacology (Berl). 115:135–140.
  • González-Maeso J, Rodríguez-Puertas R, Meana JJ, García-Sevilla JA, Guimón J. 2002. Neurotransmitter receptor-mediated activation of G-proteins in brains of suicide victims with mood disorders: selective supersensitivity of α2A-adrenoceptors. Mol Psychiatry. 7:755–767.
  • Grenhoff J, Svensson TH. 1989. Clonidine modulates dopamine cell firing in rat ventral tegmental area. Eur J Pharmacol. 165:11–18.
  • Grijalba B, Callado LF, Meana JJ, García-Sevilla JA, Pazos A. 1996. α2-Adrenoceptor subtypes in the human brain: A pharmacological delineation of [3H]RX-821002 binding to membranes and tissue sections. Eur J Pharmacol. 310:83–93.
  • Johnson SW, North RA. 1992. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci. 12:483–488.
  • Kim JO, Jeon YJ, Kim OJ, Oh SH, Kim HS, Shin BS, Oh D, Kim EJ, Cho YK, Kim NK 2014. Association between common genetic variants of α2A-, α2B- and α2C-adrenoceptors and the risk of silent brain infarction. Mol Med Rep. 9:2459–2466.
  • Kohli U, Muszkat M, Sofowora GG, Harris PA, Friedman EA, Dupont WD, et al. 2010. Effects of variation in the human alpha2A- and alpha2C-adrenoceptor genes on cognitive tasks and pain perception. Eur J Pain. 14:154–159.
  • Lonnqvist JK, Henriksson MM, Isometsa ET, Marttunen MJ, Heikkinen ME, Aro HM, et al. 1995. Mental disorders and suicide prevention. Psychiatry Clin Neurosci. 49 (Suppl 1):S111–S116.
  • Martín-Guerrero I, Callado LF, Saitua K, Rivero G, García-Orad Á, Meana JJ. 2006. The N251K functional polymorphism in the α2A-adrenoceptor gene is not associated with depression: A study in suicide completers. Psychopharmacology (Berl). 184:82–86.
  • Meana JJ, Barturen F, García-Sevilla JA. 1992. Alpha 2-adrenoceptors in the brain of suicide victims: increased receptor density associated with major depression. Biol Psychiatry. 31:471–490.
  • Meana JJ, Gonzalez-Maeso J, Garcia-Sevilla JA, Guimon J. 2000. μ-opioid receptor and α2-adrenoceptor agonist stimulation of [35S]GTPgammaS binding to G-proteins in postmortem brains of opioid addicts. Mol Psychiatry. 5:308–315.
  • Neumeister A, Charney DS, Belfer I, Geraci M, Holmes C, Sharabi Y, et al. 2005. Sympathoneural and adrenomedullary functional effects of alpha2C-adrenoreceptor gene polymorphism in healthy humans. Pharmacogenet Genomics. 15:143–149.
  • Neumeister A, Drevets WC, Belfer I, Luckenbaugh DA, Henry S, Bonne O, et al. 2006. Effects of a alpha 2C-adrenoreceptor gene polymorphism on neural responses to facial expressions in depression. Neuropsychopharmacology. 31:1750–1756.
  • Ohara K, Nagai M, Tani K, Tsukamoto T, Suzuki Y, Ohara K. 1998. Polymorphism in the promoter region of the alpha 2A adrenergic receptor gene and mood disorders. Neuroreport. 9:1291–1294.
  • Ordway GA, Jaconetta SM, Halaris AE. 1993. Characterization of subtypes of Alpha-2 adrenoceptors in the human brain. J Pharmacol Exp Ther. 264:967–976.
  • Perroud N, Aitchison KJ, Uher R, Smith R, Huezo-Diaz P, Marusic A, et al. 2009. Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP project. Neuropsychopharmacology. 34:2517–2528.
  • Piazza PV, Le Moal M. 1998. The role of stress in drug self-administration. Trends Pharmacol Sci. 19:67–71.
  • R Development Core Team. 2013. R: A language and environment for statistical computing. R Foundation for Statistical Computing. URL: http://www.R-project.org/.
  • Rihmer Z. 2007. Suicide risk in mood disorders. Curr Opin Psychiatry. 20:17–22.
  • Rivero G, Gabilondo AM, García-Sevilla JA, La Harpe R, Callado LF, Meana JJ. 2014. Increased α2- and β1-adrenoceptor densities in postmortem brain of subjects with depression: differential effect of antidepressant treatment. J Affect Disord. 167:343–350.
  • Sallinen J, Haapalinna A, MacDonald E, Viitamaa T, Lähdesmäki J, Rybnikova E, et al. 1999. Genetic alteration of the alpha2-adrenoceptor subtype c in mice affects the development of behavioral despair and stress-induced increases in plasma corticosterone levels. Mol Psychiatry. 4:443–452.
  • Sallinen J, Haapalinna A, Viitamaa T, Kobilka BK, Scheinin M. 1998. Adrenergic alpha2C-receptors modulate the acoustic startle reflex, prepulse inhibition, and aggression in mice. J Neurosci. 18:3035–3042.
  • Sallinen J, Link RE, Haapalinna A, Viitamaa T, Kulatunga M, Sjöholm B, et al. 1997. Genetic alteration of α2C-adrenoceptor expression in mice: influence on locomotor, hypothermic, and neurochemical effects of dexmedetomidine, a subtype-nonselective α2-adrenoceptor agonist. Mol Pharmacol. 51:36–46.
  • Sambrook J, Russell D 2001. Molecular cloning: a laboratory manual. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press.
  • Sequeira A, Mamdani F, Lalovic A, Anguelova M, Lesage A, Seguin M, et al. 2004. Alpha 2A adrenergic receptor gene and suicide. Psychiatry Res. 125:87–93.
  • Small KM, Forbes SL, Rahman FF, Bridges KM, Liggett SB. 2000. A four amino acid deletion polymorphism in the third intracellular loop of the human α2C-adrenergic receptor confers impaired coupling to multiple effectors. J Biol Chem. 275:23059–23064.
  • Small KM, Mialet-Perez J, Seman CA, Theiss CT, Brown KM, Liggett SB. 2004. Polymorphisms of cardiac presynaptic alpha2C adrenergic receptors: Diverse intragenic variability with haplotype-specific functional effects. Proc Natl Acad Sci USA. 101:13020–13025.
  • Small KM, Wagoner LE, Levin AM, Kardia SLR, Liggett SB. 2002. Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure. N Engl J Med. 347:1135–1142.
  • Wasserman D, Rihmer Z, Rujescu D, Sarchiapone M, Sokolowski M, Titelman D, et al. 2012. The European Psychiatric Association (EPA) guidance on suicide treatment and prevention. Eur Psychiatry. 27:129–141.
  • Williams JT, Christie MJ, Manzoni O. 2001. Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev. 81:299–343.
  • Zhang W, Klimek V, Farley JT, Zhu MY, Ordway GA. 1999. alpha2C adrenoceptors inhibit adenylyl cyclase in mouse striatum: potential activation by dopamine. J Pharmacol Exp Ther. 289:1286–1292.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.